Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody from ABBEXA LTD
Search, find, compare suppliers for anti-Von Hippel-Lindau Disease Tumor Suppressor (VHL) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Von Hippel-Lindau Disease Tumor Suppressor (VHL) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 100 µl, |
| Concentration | n/a |
| Applications | ELISA, WB, IHC |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | VHL antibody is a Rabbit polyclonal antibody against VHL. The Von Hippel-Lindau (VHL) protein is a substRate recognition component of an E3 ubiquitin ligase complex containing elongin BC (TCEB1 and TCEB2), cullin 1 (CUL1), and RING-box protein 1 (RBX1)VHL protein has been shown to exist as three distinct isoforms resulting from alternatively spliced transcript variantsLoss of VHL protein function results in a dominantly inherited familial cancer syndrome that manifests as angiomas of the retina, hemangioblastomas of the central nervous system, renal clear-cell carcinomas and pheochromocytomasUnder normoxic conditions, VHL directs the ubiquitylation and subsequent proteosomal degradation of the hypoxia inducible factor HIF alpha, maintaining very low levels of HIF alpha in the cellCellular exposure to hypoxic conditions, or loss of VHL protein function, results in increased HIF alpha protein levels and increased expression of HIF-induced gene products, many of which are angiogenesis factors such as vascular endothelial growth factor (VEGF)Thus, loss of VHL protein function is believed to contribute to the formation of highly vascular neoplasiasIn addition to HIF alpha, VHL is known to regulate the ubiquitylation of several other proteins, including tat-binding protein 1 (TBP-1), the atypical protein kinase C lambda (aPKC), and two subunits of the multiprotein RNA Polymerase II complex (RPB1 and RPB7)Interactions with elongin BC, RPB1, RPB7 and the pVHL-associated KRAB-A domain containing protein (VHLaK) suggest that VHL may also play a more direct role in transcriptional repression. |
| Immunogen | Recombinant protein of human VHL. |
| Other Names | VHL, Von Hippel-Lindau Tumor Suppressor, Protein G7, PVHL, Von Hippel-Lindau Syndrome, Elongin Binding Protein, HRCA1, RCA1, VHL1, VHL, Von Hippel-Lindau Tumor Suppressor, Protein G7, PVHL, Von Hippel-Lindau Syndrome, Elongin Binding Protein, HRCA1, RCA1, VHL1, VHL, VHL, VHL , VHL , Von Hippel-Lindau Tumor Suppressor, Von Hippel-Lindau Tumor Suppressor, Von Hippel-Lindau Tumor Suppressor , Von Hippel-Lindau Tumor Suppressor , Protein G7, Protein G7, Protein G7 , Protein G7 , PVHL, PVHL, PVHL , PVHL , Von Hippel-Lindau Syndrome, Von Hippel-Lindau Syndrome, Von Hippel-Lindau Syndrome , Von Hippel-Lindau Syndrome , Elongin Binding Protein, Elongin Binding Protein, Elongin Binding Protein , Elongin Binding Protein , HRCA1, HRCA1, HRCA1 , HRCA1 , RCA1, RCA1, RCA1 , RCA1 , VHL1, VHL1, VHL1 , VHL1 , VHL, VHL , VHL , Von Hippel-Lindau Tumor Suppressor, Von Hippel-Lindau Tumor Suppressor , Von Hippel-Lindau Tumor Suppressor , Protein G7, Protein G7 , Protein G7 , PVHL, PVHL , PVHL |
| Gene, Accession # | VHL, Gene ID: 7428, UniProt: P40337 |
| Catalog # | abx117007 |
| Price | please inquire |
| Order / More Info | Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Antibodies